Literature DB >> 27684355

Assays for the Degradation of Misfolded Proteins in Cells.

Lili Guo1, Wil Prall2, Xiaolu Yang3.   

Abstract

Protein misfolding and aggregation are associated with various neurodegenerative diseases. Cellular mechanisms that recognize and degrade misfolded proteins may serve as potential therapeutic targets. To distinguish degradation of misfolding-prone proteins from other mechanisms that regulate their levels, one important method is to measure protein half-life in cells. However, this can be challenging because misfolding-prone proteins may exist in different forms, including the native form and misfolded forms of distinct characteristics. Here we describe assays to examine the half-life of misfolded proteins in mammalian cells using a highly aggregation-prone protein, Ataxin-1 with an extended polyglutamine (polyQ) stretch, and a conformationally unstable luciferase mutant as models. Cycloheximide chase is combined with cell fractionation to examine the turnover rate of misfolding-prone proteins in various cellular fractions. We further depict a fluorescence-based assay using an enhanced green fluorescence protein (EGFP)-fusion of the luciferase mutant, which can be adapted for high throughput screening on a microplate-reader.

Entities:  

Year:  2016        PMID: 27684355      PMCID: PMC5091960          DOI: 10.3791/54266

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  29 in total

1.  Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates.

Authors:  E E Wanker; E Scherzinger; V Heiser; A Sittler; H Eickhoff; H Lehrach
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 2.  Protein degradation and protection against misfolded or damaged proteins.

Authors:  Alfred L Goldberg
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 3.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

4.  Conversion of green fluorescent protein into a toxic, aggregation-prone protein by C-terminal addition of a short peptide.

Authors:  Christopher D Link; Virginia Fonte; Brian Hiester; John Yerg; Jmil Ferguson; Susan Csontos; Michael A Silverman; Gretchen H Stein
Journal:  J Biol Chem       Date:  2005-10-19       Impact factor: 5.157

5.  Gain of function of mutant p53 by coaggregation with multiple tumor suppressors.

Authors:  Jie Xu; Joke Reumers; José R Couceiro; Frederik De Smet; Rodrigo Gallardo; Stanislav Rudyak; Ann Cornelis; Jef Rozenski; Aleksandra Zwolinska; Jean-Christophe Marine; Diether Lambrechts; Young-Ah Suh; Frederic Rousseau; Joost Schymkowitz
Journal:  Nat Chem Biol       Date:  2011-03-27       Impact factor: 15.040

6.  Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.

Authors:  Lisette G G C Verhoef; Kristina Lindsten; Maria G Masucci; Nico P Dantuma
Journal:  Hum Mol Genet       Date:  2002-10-15       Impact factor: 6.150

7.  Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.

Authors:  Andrew Fribley; Qinghua Zeng; Cun-Yu Wang
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

8.  Firefly luciferase mutants as sensors of proteome stress.

Authors:  Rajat Gupta; Prasad Kasturi; Andreas Bracher; Christian Loew; Min Zheng; Adriana Villella; Dan Garza; F Ulrich Hartl; Swasti Raychaudhuri
Journal:  Nat Methods       Date:  2011-09-04       Impact factor: 28.547

9.  Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life.

Authors:  James A Austin; Gareth S A Wright; Seiji Watanabe; J Günter Grossmann; Svetlana V Antonyuk; Koji Yamanaka; S Samar Hasnain
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-03       Impact factor: 11.205

10.  Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models.

Authors:  Sami J Barmada; Andrea Serio; Arpana Arjun; Bilada Bilican; Aaron Daub; D Michael Ando; Andrey Tsvetkov; Michael Pleiss; Xingli Li; Daniel Peisach; Christopher Shaw; Siddharthan Chandran; Steven Finkbeiner
Journal:  Nat Chem Biol       Date:  2014-06-29       Impact factor: 15.040

View more
  2 in total

1.  PDE1 inhibition facilitates proteasomal degradation of misfolded proteins and protects against cardiac proteinopathy.

Authors:  Hanming Zhang; Bo Pan; Penglong Wu; Nirmal Parajuli; Mark D Rekhter; Alfred L Goldberg; Xuejun Wang
Journal:  Sci Adv       Date:  2019-05-22       Impact factor: 14.136

2.  Formation and persistence of polyglutamine aggregates in mistranslating cells.

Authors:  Jeremy T Lant; Rashmi Kiri; Martin L Duennwald; Patrick O'Donoghue
Journal:  Nucleic Acids Res       Date:  2021-11-18       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.